These discrepancies suggest that variations in CX3CL1 and CCL3 levels may reflect subtype-specific differences in FTD, particularly in lvPPA, underscoring the importance of subtype-stratified analyses. The gene discussed is CX3CL1; the disease is frontotemporal dementia.